Page last updated: 2024-09-04

fusidic acid and mupirocin

fusidic acid has been researched along with mupirocin in 57 studies

Compound Research Comparison

Studies
(fusidic acid)
Trials
(fusidic acid)
Recent Studies (post-2010)
(fusidic acid)
Studies
(mupirocin)
Trials
(mupirocin)
Recent Studies (post-2010) (mupirocin)
1,7421173441,401214567

Research

Studies (57)

TimeframeStudies, this research(%)All Research%
pre-19904 (7.02)18.7374
1990's7 (12.28)18.2507
2000's16 (28.07)29.6817
2010's24 (42.11)24.3611
2020's6 (10.53)2.80

Authors

AuthorsStudies
Andersson, DI; Maisnier-Patin, S; Paulander, W; Pennhag, A1
Bryce, E; Gravel, D; Loeb, M; Louie, L; Matlow, A; McGeer, A; Mulvey, M; Ofner-Agostini, M; Simor, AE; Stuart, TL; Watt, C1
Apajalahti, J; Fox, J; Frimodt-Møller, N; Hansen, F; Loidl, G; Nagai, J; Siikanen, O; Takano, M; Vaara, M; Vaara, T1
Boyd, EA; Brown, D; Collins, I; Czaplewski, LG; East, SP; Fletcher, R; Gardiner, M; Haydon, DJ; Henstock, V; Ingram, P; Jones, C; Kennison, L; Noula, C; Rockley, C; Rose, V; Stokes, NR; Thomaides-Brears, HB; Ure, R; Whittaker, M1
Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD1
Apajalahti, J; Fox, J; Frimodt-Møller, N; He, H; Li, J; Nation, RL; Poudyal, A; Siikanen, O; Vaara, M; Vaara, T1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J1
Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB1
Johnston, C1
Collins, PO; Rowsell, RB; White, DG1
Gilbert, M1
Gernhardt, P; Klein, A; Possot, O; Sibold, L1
Morley, PA; Munot, LD1
Blázquez, MJ; Bouza, E; Cercenado, E; Guerrero, MC; Menarguez, MC; Moreno, S; Parras, F1
Ambler, JE; Drabu, YJ1
Pulverer, G; Schierholz, JM2
Beuth, J; Pulverer, G; Schierholz, JM1
Livingstone, V; Stringer, LJ1
Bryant, J; Gisby, J1
Afset, JE; Maeland, JA1
Coates, P; Cove, JH; Eady, EA; Layton, AM; Murtagh, MS; Ravenscroft, JC; Walker, M1
George, A; Rubin, G1
Chopra, I; Hurdle, JG; O'Neill, AJ1
Johnston, GA; Sladden, MJ1
Caldwell, F; Kreiswirth, BN; Low, DE; McGeer, A; Rousseau, J; Weese, JS; Willey, BM1
Mazereeuw-Hautier, J1
Afzal-Shah, M; Livermore, DM; Warner, M; Woodford, N1
Baines, SJ; Edwards, EA; Felmingham, D; Lloyd, DH; Loeffler, A; Milsom, SK; Toleman, MS1
Cohen, R; Gillet, Y; Moulin, F; Quinet, B; Raymond, J1
Brown, M; Kong, F; Liu, Y; Ma, L; Yang, Y; Zhang, X1
Chu Sing Lim, L; Sakharkar, KR; Sakharkar, MK; Soe, WM; Tzer Pin Lin, R1
Farrell, DJ; Love, WG; Rhys-Williams, W; Robbins, M1
Berger, M; Butler, CC; Koning, S; Morris, AD; van der Sande, R; van der Wouden, JC; van Suijlekom-Smit, LW; Verhagen, AP1
Campos, R; Gómez-González, MC; Lancho, JM; Marigliano, N; Pascua, J; Teno, P1
Anderson, M; D'Lima, L; Debabov, D; Friedman, L; Wang, L; Xu, P1
Crepinsek, MA; Crowe, L; Michener, K; Smart, NA1
Del Rosario-Quintana, C; Dorta-Hung, E; Martín-Sánchez, AM; Molina-Cabrillana, J; Quori, A; Tosco-Núñez, T1
Champion, EA; Hobbs, MM; Miller, MB; Muhlebach, MS; Popowitch, EB; Saiman, L1
Frimodt-Møller, N; Vingsbo Lundberg, C1
Lanier, J; Qui, MK; Shim, J1
Gómez-Recuero-Muñoz, L; Lozano-Masdemont, B; Pulido-Pérez, A1
Kilic, K; Sakat, MS; Ucuncu, H1
Ahn, JW; Baek, YS; Jeon, J; Song, HJ1
Abushahba, MF; Mohammad, H; Seleem, MN; Sobreira, TJ; Thangamani, S1
Best, E; Leversha, A; Ritchie, SR; Smith, A; Thomas, MG; Upton, A; Williamson, D1
Baines, SL; Carter, GP; Gonçalves da Silva, A; Heffernan, H; Howden, BP; Monk, IR; Pham, PH; Schultz, MB; Stinear, TP; Tiong, A; Williamson, DA1
Bogdan, C; Kiefer, A; Melichar, VO1
Yu, X; Zheng, H1
Doudoulakakis, A; Giormezis, N; Lebessi, E; Militsopoulou, M; Spiliopoulou, I; Syridou, G; Tsolia, M1
Chen, W; Cui, Z; He, C; Liu, Q; Shu, W; Tang, R; Yang, H; Zhang, C1
Crepinsek, MA; Michener, K; Stewart, F; Taylor, EA1
Brown, M; Dempsey, K; Kok, J; Li, C; Nahidi, S; O'Sullivan, MVN; Ramsperger, M; Shaban, RZ; Sotomayor-Castillo, C1
Andriessen, A; Benjamin, LT; Claro, C; Eichenfield, LF; Esposito, SM; Keller, L; Kircik, L; Kwong, PC; McCuaig, C; Schachner, LA1
Adam, HJ; Baxter, M; Karlowsky, JA; Lagace-Wiens, PRS; Zhanel, GG1
Abdulamir, AS; Awni, AA; Hamed, ZO1

Reviews

10 review(s) available for fusidic acid and mupirocin

ArticleYear
A systematic review and meta-analysis of treatments for impetigo.
    The British journal of general practice : the journal of the Royal College of General Practitioners, 2003, Volume: 53, Issue:491

    Topics: Administration, Topical; Adolescent; Algorithms; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Family Practice; Fusidic Acid; Humans; Impetigo; Infant; Infant, Newborn; Mupirocin; Randomized Controlled Trials as Topic; Treatment Outcome

2003
Current options for the treatment of impetigo in children.
    Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:13

    Topics: Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Erythromycin; Fusidic Acid; Humans; Impetigo; Infant; Mupirocin; Randomized Controlled Trials as Topic; Staphylococcal Scalded Skin Syndrome; Staphylococcus aureus; Streptococcus pyogenes

2005
[Impetigo].
    Annales de dermatologie et de venereologie, 2006, Volume: 133, Issue:2

    Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Azithromycin; Cephalosporins; Child; Clavulanic Acid; Clinical Trials as Topic; Diagnosis, Differential; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Impetigo; Infant; Male; Methicillin; Mupirocin; Ointments; Penicillins; Pregnancy; Pristinamycin; Sulfadiazine; Time Factors

2006
Interventions for impetigo.
    The Cochrane database of systematic reviews, 2012, Jan-18, Volume: 1

    Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Erythromycin; Fusidic Acid; Humans; Impetigo; Mupirocin; Penicillins; Randomized Controlled Trials as Topic

2012
Interventions for preventing mastitis after childbirth.
    The Cochrane database of systematic reviews, 2012, Oct-17, Volume: 10

    Topics: Anti-Bacterial Agents; Breast Feeding; Edible Grain; Female; Fusidic Acid; Humans; Mastitis; Mupirocin; Neuropeptides; Ointments; Patient Education as Topic; Randomized Controlled Trials as Topic

2012
Clinical inquiry: what is the best treatment for impetigo ?
    The Journal of family practice, 2014, Volume: 63, Issue:6

    Topics: Administration, Topical; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacitracin; Bridged Bicyclo Compounds, Heterocyclic; Cephalexin; Clindamycin; Cloxacillin; Dicloxacillin; Diterpenes; Erythromycin; Fusidic Acid; Gentamicins; Humans; Impetigo; Meta-Analysis as Topic; Mupirocin; Randomized Controlled Trials as Topic

2014
Staphylococcus lugdunensis: An Emerging Pathogen in Skin and Soft Tissue Infections.
    Actas dermo-sifiliograficas, 2015, Volume: 106, Issue:9

    Topics: Abscess; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Communicable Diseases, Emerging; Female; Foot Diseases; Fusidic Acid; Humans; Insect Bites and Stings; Male; Middle Aged; Mupirocin; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus lugdunensis; Wound Infection

2015
A bug in the ointment: topical antimicrobial usage and resistance in New Zealand.
    The New Zealand medical journal, 2015, Dec-04, Volume: 128, Issue:1426

    Topics: Administration, Topical; Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Fusidic Acid; Humans; Methicillin-Resistant Staphylococcus aureus; Mupirocin; New Zealand

2015
Interventions for preventing mastitis after childbirth.
    The Cochrane database of systematic reviews, 2020, 09-29, Volume: 9

    Topics: Anti-Bacterial Agents; Bias; Breast Feeding; Edible Grain; Female; Fusidic Acid; Humans; Massage; Mastitis; Mupirocin; Neuropeptides; Ointments; Patient Education as Topic; Placebos; Probiotics; Randomized Controlled Trials as Topic

2020
Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo.
    Journal of drugs in dermatology : JDD, 2021, 02-01, Volume: 20, Issue:2

    Topics: Aminopyridines; Anti-Bacterial Agents; Antimicrobial Stewardship; Bridged Bicyclo Compounds, Heterocyclic; Critical Pathways; Delphi Technique; Diterpenes; Drug Resistance, Bacterial; Evidence-Based Medicine; Fusidic Acid; Humans; Impetigo; Microbial Sensitivity Tests; Mupirocin; Practice Guidelines as Topic; Quinolones; Skin Cream; Staphylococcus aureus; Streptococcus pyogenes; Systematic Reviews as Topic

2021

Trials

7 trial(s) available for fusidic acid and mupirocin

ArticleYear
Topical antibiotics in the treatment of superficial skin infections in general practice--a comparison of mupirocin with sodium fusidate.
    The Journal of infection, 1989, Volume: 18, Issue:3

    Topics: Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Child; Child, Preschool; Fatty Acids; Fusidic Acid; Humans; Infant; Middle Aged; Multicenter Studies as Topic; Mupirocin; Random Allocation; Skin Diseases, Infectious; Staphylococcus aureus; Streptococcus

1989
Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections.
    Journal of the American Academy of Dermatology, 1989, Volume: 20, Issue:6

    Topics: Administration, Topical; Anti-Bacterial Agents; Bacterial Infections; Drug Evaluation; Fatty Acids; Female; Fusidic Acid; Humans; Male; Mupirocin; Ointments; Random Allocation; Skin Diseases, Infectious

1989
A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis.
    Current medical research and opinion, 1988, Volume: 11, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Fatty Acids; Female; Fusidic Acid; Humans; Impetigo; Infant; Male; Middle Aged; Mupirocin; Ointments; Skin Diseases, Infectious

1988
Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:1

    Topics: Administration, Oral; Administration, Topical; Cross Infection; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Male; Methicillin Resistance; Middle Aged; Mupirocin; Nasal Cavity; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination

1995
The treatment of Staphyloccocus aureus infected sore nipples: a randomized comparative study.
    Journal of human lactation : official journal of International Lactation Consultant Association, 1999, Volume: 15, Issue:3

    Topics: Administration, Cutaneous; Administration, Oral; Anti-Bacterial Agents; Breast Diseases; Female; Fusidic Acid; Humans; Mupirocin; Nipples; Pain; Prospective Studies; Staphylococcal Skin Infections; Staphylococcus aureus

1999
Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema.
    The British journal of dermatology, 2003, Volume: 148, Issue:5

    Topics: Administration, Topical; Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; Carrier State; Chi-Square Distribution; Child; Child, Preschool; Dermatitis, Atopic; Drug Resistance, Microbial; Female; Fusidic Acid; Humans; Male; Middle Aged; Mupirocin; Sex Factors; Staphylococcus aureus; Statistics, Nonparametric; Time Factors; Treatment Outcome

2003
Infections after photodynamic therapy in Condyloma acuminatum patients: incidence and management.
    Environmental science and pollution research international, 2018, Volume: 25, Issue:14

    Topics: Adolescent; Adult; Aminolevulinic Acid; Anti-Bacterial Agents; Bacterial Infections; Beijing; Condylomata Acuminata; Female; Fusidic Acid; Genital Diseases, Female; Genital Diseases, Male; Humans; Incidence; Male; Middle Aged; Mupirocin; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Young Adult

2018

Other Studies

40 other study(ies) available for fusidic acid and mupirocin

ArticleYear
Caenorhabditis elegans as a model to determine fitness of antibiotic-resistant Salmonella enterica serovar typhimurium.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2

    Topics: Animals; Caenorhabditis elegans; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Mice; Salmonella Infections, Animal; Salmonella typhimurium

2007
Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11

    Topics: Aged; Anti-Bacterial Agents; Canada; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Infections; Staphylococcus aureus

2007
Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Cricetinae; Fibroblasts; Gram-Negative Bacteria; Kidney Cortex; Lung; Microbial Sensitivity Tests; Microvilli; Polymyxin B; Rats; Structure-Activity Relationship

2008
Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZ.
    Bioorganic & medicinal chemistry letters, 2009, Jan-15, Volume: 19, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Benzamides; Cytoskeletal Proteins; Microbial Sensitivity Tests; Staphylococcus; Structure-Activity Relationship

2009
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity

2010
A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Cell Membrane Permeability; Cricetinae; Cricetulus; Drug Synergism; Fibroblasts; Gram-Negative Bacteria; Guinea Pigs; Lung; Male; Microbial Sensitivity Tests; Polymyxin B; Rats; Structure-Activity Relationship

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
    European journal of medicinal chemistry, 2017, Feb-15, Volume: 127

    Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes

2017
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
    Journal of medicinal chemistry, 2017, 05-11, Volume: 60, Issue:9

    Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure

2017
Topical 2% mupirocin versus 2% sodium fusidate ointment in the treatment of primary and secondary skin infections.
    Journal of the American Academy of Dermatology, 1991, Volume: 24, Issue:5 Pt 1

    Topics: Administration, Cutaneous; Anti-Bacterial Agents; Fatty Acids; Fusidic Acid; Humans; Impetigo; Mupirocin; Ointments

1991
Analysis of drug resistance in the archaebacterium Methanococcus voltae with respect to potential use in genetic engineering.
    Applied and environmental microbiology, 1988, Volume: 54, Issue:3

    Topics: Anti-Bacterial Agents; Culture Media; Drug Resistance, Microbial; Euryarchaeota; Fatty Acids; Fusidic Acid; Gene Expression Regulation; Genes, Bacterial; Methionine Sulfoximine; Mupirocin; Puromycin; R Factors; Transfection

1988
Mupirocin-resistant methicillin-resistant Staphylococcus aureus.
    The Journal of hospital infection, 1996, Volume: 32, Issue:1

    Topics: Administration, Topical; Anti-Bacterial Agents; Bacitracin; Drug Interactions; Drug Resistance, Microbial; Fusidic Acid; Humans; Methicillin Resistance; Mupirocin; Polymyxin B; Staphylococcal Infections; Staphylococcus aureus

1996
Development of a new CSF-shunt with sustained release of an antimicrobial broad-spectrum combination.
    Zentralblatt fur Bakteriologie : international journal of medical microbiology, 1997, Volume: 286, Issue:1

    Topics: Bacteria; Bacterial Adhesion; Cerebrospinal Fluid Shunts; Delayed-Action Preparations; Drug Resistance, Microbial; Drug Therapy, Combination; Equipment Contamination; Fusidic Acid; Microbial Sensitivity Tests; Mupirocin; Rifampin; Silicones

1997
Investigation of a rifampin, fusidic-acid and mupirocin releasing silicone catheter.
    Biomaterials, 1998, Volume: 19, Issue:22

    Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacterial Adhesion; Biocompatible Materials; Catheterization; Cerebrospinal Fluid Shunts; Delayed-Action Preparations; Erythrocytes; Fusidic Acid; Hemolysis; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Mupirocin; Rifampin; Silicones; Staphylococcus aureus; Staphylococcus epidermidis

1998
Killing effects of antibiotics and two-fold antimicrobial combinations on proliferating and non growing staphylococci.
    Zentralblatt fur Bakteriologie : international journal of medical microbiology, 1998, Volume: 288, Issue:4

    Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Erythromycin; Fusidic Acid; Humans; Microbial Sensitivity Tests; Mupirocin; Prostheses and Implants; Rifampin; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis

1998
Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:2

    Topics: Administration, Oral; Administration, Topical; Animals; Anti-Bacterial Agents; Bacitracin; Cephalexin; Chemistry, Pharmaceutical; Cricetinae; Erythromycin; Female; Floxacillin; Fusidic Acid; Impetigo; Male; Mice; Mupirocin; Neomycin; Penicillins; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus; Wound Infection

2000
Susceptibility of skin and soft-tissue isolates of Staphylococcus aureus and Streptococcus pyogenes to topical antibiotics: indications of clonal spread of fusidic acid-resistant Staphylococcus aureus.
    Scandinavian journal of infectious diseases, 2003, Volume: 35, Issue:2

    Topics: Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Bacitracin; Child; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Fusidic Acid; Genes, Bacterial; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mupirocin; Probability; Sensitivity and Specificity; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes

2003
Anti-staphylococcal activity of indolmycin, a potential topical agent for control of staphylococcal infections.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:2

    Topics: Anti-Infective Agents, Local; Drug Resistance, Bacterial; Fusidic Acid; Geobacillus stearothermophilus; Indoles; Mupirocin; Staphylococcal Infections; Staphylococcus aureus; Tryptophan-tRNA Ligase

2004
An outbreak of methicillin-resistant Staphylococcus aureus skin infections resulting from horse to human transmission in a veterinary hospital.
    Veterinary microbiology, 2006, Apr-16, Volume: 114, Issue:1-2

    Topics: Adult; Animals; Animals, Newborn; Community-Acquired Infections; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Fusidic Acid; Horse Diseases; Horses; Hospitals, Animal; Humans; Methicillin Resistance; Mupirocin; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Zoonoses

2006
In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Bridged Bicyclo Compounds, Heterocyclic; Diterpenes; DNA Mutational Analysis; Drug Resistance, Bacterial; Fusidic Acid; Humans; Microbial Sensitivity Tests; Mupirocin; Ribosomal Protein L3; Ribosomal Proteins; Staphylococcal Infections; Staphylococcus aureus; United Kingdom

2008
In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:6

    Topics: Animals; Animals, Domestic; Anti-Bacterial Agents; Carrier State; Cats; Coagulase; Dogs; Fusidic Acid; Germany; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Infections; Staphylococcus; United Kingdom

2008
[Managing children skin and soft tissue infections].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2008, Volume: 15 Suppl 2

    Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cellulitis; Cephalosporins; Child; Drug Resistance, Bacterial; Fasciitis, Necrotizing; Furunculosis; Fusidic Acid; Humans; Impetigo; Injections, Intravenous; Macrolides; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Penicillins; Pristinamycin; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Scalded Skin Syndrome; Staphylococcal Skin Infections; Staphylococcus aureus; Stevens-Johnson Syndrome; Streptococcal Infections; Streptococcus pyogenes

2008
Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous.
    The British journal of dermatology, 2009, Volume: 161, Issue:6

    Topics: Anti-Bacterial Agents; Child; Child, Preschool; China; DNA, Bacterial; Female; Fusidic Acid; Humans; Impetigo; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Skin Infections; Virulence Factors

2009
In vitro drug interactions of gallates with antibiotics in Staphylococcus Aureus.
    Frontiers in bioscience (Elite edition), 2010, 01-01, Volume: 2, Issue:2

    Topics: Anti-Bacterial Agents; Catechin; Drug Interactions; Fusidic Acid; Gallic Acid; In Vitro Techniques; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Tetracycline

2010
Investigation of the potential for mutational resistance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage study.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:3

    Topics: Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Daptomycin; Diterpenes; Fusidic Acid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Mupirocin; Polymerase Chain Reaction; Porphyrins; Sequence Analysis, DNA; Vancomycin

2011
[Colonization management of methicillin resistant Staphylococcus aureus in patients and health professional in the haemodialysis unit in a situation of high risk of endemic disease: looking for zero nasal carriers?].
    Enfermedades infecciosas y microbiologia clinica, 2012, Volume: 30, Issue:3

    Topics: Adult; Algorithms; Bacterial Load; Carrier State; Cross Infection; Disease Reservoirs; Endemic Diseases; Fusidic Acid; Hemodialysis Units, Hospital; Humans; Infection Control; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Nasal Cavity; Patients; Personnel, Hospital; Prevalence; Risk; Staphylococcal Infections

2012
No decrease in susceptibility to NVC-422 in multiple-passage studies with methicillin-resistant Staphylococcus aureus, S. aureus, Pseudomonas aeruginosa, and Escherichia coli.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Ciprofloxacin; Diterpenes; Drug Resistance, Multiple, Bacterial; Escherichia coli; Fusidic Acid; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Pseudomonas aeruginosa; Staphylococcus aureus; Taurine

2012
[Antibiotic ointments and methicillin-resistant Staphylococcus aureus with a reservoir in a healthcare worker in a tertiary hospital].
    Enfermedades infecciosas y microbiologia clinica, 2013, Volume: 31, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Carrier State; Cross Infection; Disease Outbreaks; Disease Reservoirs; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Fusidic Acid; Humans; Incidence; Infectious Disease Transmission, Professional-to-Patient; Male; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Nasal Cavity; Nursing Assistants; Ointments; Personnel, Hospital; Retrospective Studies; Spain; Staphylococcal Infections; Tertiary Care Centers

2013
Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.
    Pediatric pulmonology, 2014, Volume: 49, Issue:3

    Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Bronchoscopy; Child; Child, Preschool; Cohort Studies; Cystic Fibrosis; DNA, Bacterial; Exotoxins; Female; Fosfomycin; Fusidic Acid; Humans; Leukocidins; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Molecular Typing; Mupirocin; Oxazolidinones; Penicillin-Binding Proteins; Pharynx; Pneumonia, Staphylococcal; Sequence Analysis, DNA; Sputum; Staphylococcal Infections; Staphylococcal Protein A; Tetracycline; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States

2014
Efficacy of topical and systemic antibiotic treatment of meticillin-resistant Staphylococcus aureus in a murine superficial skin wound infection model.
    International journal of antimicrobial agents, 2013, Volume: 42, Issue:3

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacterial Load; Bridged Bicyclo Compounds, Heterocyclic; Diterpenes; Female; Fusidic Acid; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mupirocin; Oxazolidinones; Staphylococcal Skin Infections; Vancomycin; Wound Infection

2013
Nasal Vestibular Furunculosis Presenting as the Rudolph Sign.
    The Journal of craniofacial surgery, 2015, Volume: 26, Issue:6

    Topics: Administration, Intranasal; Administration, Oral; Animals; Anti-Bacterial Agents; Edema; Female; Furunculosis; Fusidic Acid; Humans; Middle Aged; Mupirocin; Nose Diseases; Staphylococcal Infections

2015
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
    International journal of dermatology, 2016, Volume: 55, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult

2016
Repurposing auranofin for the treatment of cutaneous staphylococcal infections.
    International journal of antimicrobial agents, 2016, Volume: 47, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Auranofin; Biofilms; Cell Line; Chemokine CCL2; Drug Repositioning; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Interleukin-1beta; Interleukin-6; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Skin Infections; Staphylococcus epidermidis; Tumor Necrosis Factor-alpha

2016
Topical Antibiotic Use Coselects for the Carriage of Mobile Genetic Elements Conferring Resistance to Unrelated Antimicrobials in Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:2

    Topics: Administration, Topical; Anti-Bacterial Agents; Bayes Theorem; Drug Resistance, Multiple, Bacterial; Fusidic Acid; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Mupirocin; New Zealand; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus

2018
Successful eradication of newly acquired MRSA in six of seven patients with cystic fibrosis applying a short-term local and systemic antibiotic scheme.
    BMC pulmonary medicine, 2018, Jan-25, Volume: 18, Issue:1

    Topics: Administration, Inhalation; Administration, Intranasal; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Baths; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Fusidic Acid; Hand Disinfection; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Retrospective Studies; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult

2018
Emergence of staphylococcal scalded skin syndrome associated with a new toxinogenic, methicillin-susceptible Staphylococcus aureus clone.
    Journal of medical microbiology, 2019, Volume: 68, Issue:1

    Topics: Anti-Bacterial Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Fusidic Acid; Humans; Infant; Infant, Newborn; Male; Methicillin; Mupirocin; Staphylococcal Scalded Skin Syndrome; Staphylococcus aureus

2019
Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus with mupirocin, fusidic acid and/or retapamulin resistance.
    BMC microbiology, 2020, 06-29, Volume: 20, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Bridged Bicyclo Compounds, Heterocyclic; China; Diterpenes; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fusidic Acid; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mupirocin; Mutation; Prevalence; Sequence Analysis, DNA; Staphylococcal Infections

2020
Outbreak of community-acquired Staphylococcus aureus skin infections in an Australian professional football team.
    Journal of science and medicine in sport, 2021, Volume: 24, Issue:6

    Topics: Administration, Intranasal; Anti-Bacterial Agents; Anti-Infective Agents, Local; Australia; Chlorhexidine; Community-Acquired Infections; Cross-Sectional Studies; Disease Outbreaks; Football; Fusidic Acid; Genome, Bacterial; Humans; Hygiene; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Ointments; Retrospective Studies; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus

2021
In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007-18).
    The Journal of antimicrobial chemotherapy, 2021, 06-18, Volume: 76, Issue:7

    Topics: Aminopyridines; Anti-Bacterial Agents; Canada; Fusidic Acid; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Quinolones; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus

2021
Novel recombinant endolysin ointment with broad antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from wounds and burns.
    Archives of microbiology, 2023, Mar-04, Volume: 205, Issue:4

    Topics: Anti-Bacterial Agents; Bacteriophages; Burns; Fusidic Acid; Humans; Methicillin-Resistant Staphylococcus aureus; Mupirocin; N-Acetylmuramoyl-L-alanine Amidase; Ointments; Staphylococcus aureus

2023